Gabriel Leung - 07 Jun 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
By: /s/ Steven Robbins, Attorney in Fact for Kinyip Gabriel Leung
Issuer symbol
NVCR
Transactions as of
07 Jun 2021
Net transactions value
-$173,100
Form type
4
Filing time
08 Jun 2021, 16:49:40 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $31,450 +1,000 +1.4% $31.45 73,045 07 Jun 2021 Direct
transaction NVCR Ordinary Shares Sale $204,550 -1,000 -1.4% $204.55 72,045 07 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1,000 -19% $0.000000 4,345 07 Jun 2021 Ordinary Shares 1,000 $31.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
F2 Fully vested as of the date hereof.